Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3204]

STRIDE ± lenvatinib plus TACE improves outcomes in unresectable early-to...

Dr Ghassan K. Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA

STRIDE ± lenvatinib plus TACE improves outcomes in unresectable early-to-intermediate HCC ( Dr Ghassan K. Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA )

Early ctDNA clearance linked to improved outcomes in KRAS G12C-mutant...

Dr Filippo Pietrantonio - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan...

Early ctDNA clearance linked to improved outcomes in KRAS G12C-mutant colorectal cancer ( Dr Filippo Pietrantonio - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy )

GLP-1 receptor agonists show modest breast cancer prevention benefit in high...

Dr Nico-Al P. Gotera - UT Health San Antonio, Texas, USA

GLP-1 receptor agonists show modest breast cancer prevention benefit in high-risk women with obesity ( Dr Nico-Al P. Gotera - UT Health San Antonio, Texas, USA )

Giredestrant plus palbociclib shows limited benefit in ER-positive, HER2...

Dr Mabel Mardones - Rocky Mountain Cancer Centers, Denver, USA

Giredestrant plus palbociclib shows limited benefit in ER-positive, HER2-negative metastatic breast cancer ( Dr Mabel Mardones - Rocky Mountain Cancer Centers, Denver, USA )

Concurrent thoracic radiotherapy plus chemo-ICI shows no overall survival...

Dr Bjorn Henning Gronberg - Norwegian University of Science and Technology...

Concurrent thoracic radiotherapy plus chemo-ICI shows no overall survival benefit in ES-SCLC ( Dr Bjorn Henning Gronberg - Norwegian University of Science and Technology, Trondheim, Norway )

Amivantamab plus pembrolizumab and carboplatin in R/M HNSCC: Evaluating...

Dr Barbara Burtness - Yale School of Medicine, New Haven, USA

Amivantamab plus pembrolizumab and carboplatin in R/M HNSCC: Evaluating improved response and survival vs chemo ( Dr Barbara Burtness - Yale School of Medicine, New Haven, USA )

Talazoparib plus enzalutamide improves radiographic progression-free survival...

Dr Neeraj Agarwal - University of Utah, Salt Lake City, USA

Talazoparib plus enzalutamide improves radiographic progression-free survival in HRR-altered mCSPC ( Dr Neeraj Agarwal - University of Utah, Salt Lake City, USA )

Sacituzumab govitecan improves PFS across Trop-2, BRCA, and HER2 metastatic...

Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA

Sacituzumab govitecan improves PFS across Trop-2, BRCA, and HER2 metastatic triple-negative breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )

Sacituzumab govitecan plus pembrolizumab improves PFS across biomarker...

Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA

Sacituzumab govitecan plus pembrolizumab improves PFS across biomarker subgroups in metastatic triple-negative breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )

1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical...

Helena Ullgren, Rachel Powell, Irati Rodriguez-Matesanz and Elin Backman...

1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical guidance for oncology nurses ( Helena Ullgren, Rachel Powell, Irati Rodriguez-Matesanz and Elin Backman Stålnacke )

2: Managing EGFR inhibitor side effects in NSCLC - Skin toxicity impact...

Helena Ullgren, Rachel Powell, Patrick Jahn and Elin Backman Stålnacke

2: Managing EGFR inhibitor side effects in NSCLC - Skin toxicity impact, adherence challenges, and nursing management ( Helena Ullgren, Rachel Powell, Patrick Jahn and Elin Backman Stålnacke )

3: MDT collaboration in NSCLC - Aligning oncologists, nurses, and patients to...

Helena Ullgren, Elin Backman Stålnacke, Dr Pascale Tomasini and Gini Harrison

3: MDT collaboration in NSCLC - Aligning oncologists, nurses, and patients to enhance EGFR inhibitor treatment pathways and supportive care ( Helena Ullgren, Elin Backman Stålnacke, Dr Pascale Tomasini and Gini Harrison )

More from ecancer